0000899243-21-023341.txt : 20210611 0000899243-21-023341.hdr.sgml : 20210611 20210611183131 ACCESSION NUMBER: 0000899243-21-023341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210609 FILED AS OF DATE: 20210611 DATE AS OF CHANGE: 20210611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azad Babak CENTRAL INDEX KEY: 0001822193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39549 FILM NUMBER: 211012681 MAIL ADDRESS: STREET 1: 233 WILSHIRE ROAD CITY: SANTA MONICA STATE: CA ZIP: 90410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GoodRx Holdings, Inc. CENTRAL INDEX KEY: 0001809519 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 475104396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 OLYMPIC BOULEVARD CITY: SANTA MONICA STATE: CA ZIP: 90404 BUSINESS PHONE: (855) 268-2822 MAIL ADDRESS: STREET 1: 2701 OLYMPIC BOULEVARD CITY: SANTA MONICA STATE: CA ZIP: 90404 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-09 0 0001809519 GoodRx Holdings, Inc. GDRX 0001822193 Azad Babak C/O GOODRX HOLDINGS, INC. 2701 OLYMPIC BOULEVARD SANTA MONICA CA 90404 0 1 0 0 See Remarks Class A Common Stock 2021-06-09 4 M 0 12500 5.94 A 12500 D Class A Common Stock 2021-06-09 4 S 0 4229 38.5017 D 8271 D Class A Common Stock 2021-06-09 4 S 0 7711 39.587 D 560 D Class A Common Stock 2021-06-09 4 S 0 560 40.3011 D 0 D Stock Option (Right to Buy) 5.94 2021-06-09 4 M 0 12500 0.00 D 2030-01-30 Class A Common Stock 12500 399584 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.15 to $39.14. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This price reported in Column 4 is a werighted average price. These shares were sold in multiple transactions at prices ranging from $39.17 to $40.16. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This price reported in Column 4 is a werighted average price. These shares were sold in multiple transactions at prices ranging from $40.18 to $40.40. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on October 9, 2019. /s/ Gracye Cheng, as Attorney-in-Fact for Babak Azad 2021-06-11